Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.12 per share when it actually produced a loss of $0.12, delivering no surprise.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Hyperfine, which belongs to the Zacks Medical - ...

Hyperfine (HYPR) Q2 2025 Earnings Call August 13, 2025 04:30 PM ET Speaker0Good afternoon, and welcome to HyperFine's Second Quarter twenty twenty five Earnings Conference Call. Currently, all participants are in listen only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Webb Campbell from Gilmartin Group for introductory disclosure.Speaker1Thank you for joi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 10-Q _________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to_________ Commission File Number: 001-39949 _________________ Hyperfine, Inc. (Exact name of registrant as spe ...

Exhibit 99.1 Hyperfine, Inc. Reports Second Quarter 2025 Financial Results GUILFORD, Connecticut, August 13, 2025 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced second quarter 2025 financial results and provided a business update. "In the second quarter, we executed across our key growth drivers. We rec ...

GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced second quarter 2025 financial results and provided a business update. “In the second quarter, we executed across our key growth drivers. We received FDA clearances for our latest software, Optive AITM, and for the next genera ...

Product & Technology - Hyperfine launched the next-generation Swoop system with Optive AI software in mid-2025, which is the first FDA-cleared, AI-powered portable MR brain imaging system[4,74] - The Swoop system is designed to improve brain health globally by expanding brain MR imaging to multiple healthcare settings[4,10] - The new Swoop system powered by Optive AI software brings image quality closer to conventional 1.5T MRI[40,75] Market Opportunity & Growth Strategy - The company estimates a total addressable market (TAM) exceeding $6 billion, potentially expanding to over $16 billion with new sites of care[4,19] - Hyperfine has an installed base of over 180 Swoop systems globally as of June 2025[60] - The company's growth strategy focuses on expanding to new sites of care, including emergency departments, clinics, and neurology offices, as well as geographic expansion[74] Financial Performance - Hyperfine anticipates revenue between $27 million and $29 million for FY25, with gross margins between 47% and 50%[71] - The company projects a 10-20% year-over-year revenue growth for 2025[68] - Hyperfine had $25.4 million in cash and cash equivalents as of June 30, 2025, with a cash runway expected to last until the end of 2026[71]

Hyperfine (HYPR) 2025 Conference June 05, 2025 04:20 PM ET Speaker0 Alright. We're kicking off the next session here. My name is Young Lee, one of the med tech analysts at Jefferies, and pleased to be joined by Hyperfine. From the company, we have the CEO to my right, Maria Sainz. I guess I'll just pass the floor off to you for the presentation. Thank you. Speaker1 Thank you, and thank you for, inviting me. I'm very excited to be here. Here are our disclosures. I'm actually very excited to be here today. Hy ...

Core Insights - Hyperfine (HYPR) has received FDA 510(k) clearance for its next-generation Swoop Portable MR Imaging system, which utilizes proprietary OptiVu AI software to enhance image quality and usability [1][4][8] Company Developments - The FDA clearance enhances Hyperfine's commitment to bedside imaging, allowing for rapid, low-field MRI capabilities without the logistical challenges of traditional systems [2] - The Swoop system is designed to improve clinical utility and operational efficiency in hospitals and care teams, making it more competitive against conventional MRI systems [4][10] - The upgraded Swoop system features a new hardware platform and OptiVu AI software, providing the highest signal-to-noise ratio to date, resulting in exceptional image quality and faster acquisition times [9][10] - The system is tailored for a broad patient population, including pediatric and elderly patients, and is particularly beneficial in emergency departments and under-resourced locations [10][11] Market Position and Financials - Following the FDA announcement, HYPR's shares increased by 41%, closing at $0.85, although the company has seen a 3.4% decline year-to-date compared to a 9.7% decline in the industry [3] - Hyperfine currently has a market capitalization of $46.89 billion and has delivered an average earnings surprise of 3.1% over the trailing four quarters [5] Industry Outlook - The global portable MRI market is projected to grow from $4.34 billion in 2025 to around $7 billion by 2034, with a CAGR of 5.44% from 2024 to 2034, indicating a favorable market environment for Hyperfine's Swoop system [12]

Hyperfine (HYPR) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Company Participants Webb Campbell - Investor RelationsMaria Sainz - CEO, President & DirectorBrett Hale - CFO & Chief Administrative OfficerYuan Zhi - Managing Director Conference Call Participants Frank Takkinen - Senior Research AnalystNone - Analyst Operator Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Hyperfine Q1 twenty twenty five Earnings ...

Hyperfine (HYPR) Q1 2025 Earnings Call May 13, 2025 04:30 PM ET Speaker0 Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Hyperfine Q1 twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. Thank you. I would now like to turn the call over to Webb Campbell, Investor Relations. Please go ahead. S ...